Millions of people fall ill with the flu every year, and adults age 65 and older are at higher risk of developing serious ...

RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...

Deutsche Bank raised the firm’s price target on CVS Health (CVS) to $70 from $66 and keeps a Buy rating on the shares. The company issued a ...

On Jan. 23, WWD reported that, according to Coresight Research, a research and advisory firm specializing in retail and ...

HARTFORD— This week, the CEO of CVS Health expressed confidence that the company would turn around its embattled health-insurance business, the Hartford- based Aetna. CVS' reputation in Connecticut ...

CVS Health (NYSE:CVS – Free Report) had its target price increased by Wolfe Research from 67.00 to 70.00 in a report ...

CVS Health (NYSE:CVS – Free Report) had its price objective decreased by UBS Group from $62.00 to $59.00 in a research note ...

The positive investor sentiment on CVS is due to the pharmacy chain operator's fourth-quarter earnings report, which were published early Wednesday morning. The company squeaked past the consensus ...

CVS Health CEO David Joyner sees a way to create a more efficient healthcare professional network under the CVS umbrella.

During the last three months, 11 analysts shared their evaluations of CVS Health CVS +0.18% Get Free Report , revealing ...